Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,208 | 25,930 | 30,271 | 36,449 | 35,411 |
| Marketable Securities | 31,701 | 46,744 | 48,878 | 64,899 | 63,901 |
| Receivables | 4,164 | 3,950 | 5,287 | 3,406 | 2,370 |
| Inventories | 11,621 | 11,978 | 13,457 | 11,335 | 11,398 |
| TOTAL | $86,207 | $90,189 | $99,522 | $117,760 | $114,137 |
| Non-Current Assets | |||||
| PPE Net | 7,855 | 6,428 | 6,743 | 6,601 | 7,034 |
| Other Non-Current Assets | 5,715 | 153 | 156 | 29 | 471 |
| TOTAL | $13,570 | $6,581 | $6,899 | $6,630 | $7,505 |
| Total Assets | $99,777 | $96,770 | $106,421 | $124,390 | $121,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,097 | 5,818 | 6,924 | 5,608 | 5,845 |
| Accrued Expenses | 11,342 | 11,316 | 9,438 | 11,441 | 8,726 |
| Other current liabilities | 627 | 991 | 1,410 | 1,534 | 2,477 |
| TOTAL | $38,754 | $39,017 | $38,411 | $31,489 | $29,140 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,808 | 14,567 | 14,339 | 13,991 | 13,914 |
| Deferred Revenues | 20,688 | 20,892 | 20,639 | 12,906 | 12,092 |
| Other Non-Current Liabilities | 2,248 | 3,091 | 3,055 | 3,097 | 3,204 |
| TOTAL | $19,653 | $23,917 | $27,538 | $37,952 | $39,467 |
| Total Liabilities | $58,407 | $62,934 | $65,949 | $69,441 | $68,607 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,041 | 74,969 | 74,566 | 74,516 | 71,356 |
| Common Shares | 76 | 75 | 75 | 74 | 71 |
| Retained earnings | -711,760 | -713,581 | -701,646 | -681,473 | -662,498 |
| Other shareholders' equity | 6 | 12 | 16 | 9 | 23 |
| TOTAL | $41,370 | $33,836 | $40,472 | $54,949 | $53,035 |
| Total Liabilities And Equity | $99,777 | $96,770 | $106,421 | $124,390 | $121,642 |